GlassScriptPhysician profile
Charles S Yanofsky
NPI 1669433587
$1,183.08
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $498 · 2020: $62.74 · 2021: $216 · 2022: $406.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $298.90 | 2020-2022 | |
| Greenwich Biosciences, INC. | $249.57 | 2019 | |
| Biogen, INC. | $172.16 | 2019 | |
| Celgene Corporation | $160.83 | 2022 | |
| Allergan, INC. | $135.74 | 2019-2021 | |
| Alexion Pharmaceuticals, INC. | $100.80 | 2022 | |
| Novartis Pharmaceuticals Corporation | $47.98 | 2019 | |
| Lundbeck LLC | $17.10 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Yanofsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.